Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancers

ISSN： 0141-5492

Source： Biotechnology Letters, Vol.33, Iss.2, 2011-02, pp. : 221-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of human interferon-γ biosynthesis by antisense oligodeoxynucleotides

By Boeve Christine Ley Marc

Molecular Biotechnology, Vol. 14, Iss. 2, 2000-02 ,pp. : 157-163

Humana Press, Inc

Access to resources Recommend Favorite

Molecular Characterization of p53 Mutations in Primary and Secondary Liver Tumors

By Tullo A. Sbisà E.

Molecular Biotechnology, Vol. 21, Iss. 3, 2002-07 ,pp. : 265-278

Humana Press, Inc

Access to resources Recommend Favorite

Gene interference using antisense oligodeoxynucleotides on whole chick embryos: Optimal ring and roller-bottle culture technique

By Cooke Jonathan Isaac Alison

Molecular Biotechnology, Vol. 15, Iss. 3, 2000-07 ,pp. : 259-277

Humana Press, Inc

Access to resources Recommend Favorite

CAGE Displays Oncogenic Potential and Induces Cytolytic T Lymphocyte Activity

By Shim Eunsook Shim Hyeeun Bae Jinhee Lee Hansoo Jeoung Dooil

Biotechnology Letters, Vol. 28, Iss. 7, 2006-04 ,pp. : 515-522

Springer Publishing Company

Access to resources Recommend Favorite

Intracellular antibodies: development and therapeutic potential

By Richardson J.H. Marasco W.A.

Trends in Biotechnology, Vol. 13, Iss. 8, 1995-08 ,pp. : 306-310

Elsevier

Access to resources Recommend Favorite